The Vanguard Russell 2000 ETF (VTWO), which tracks small-cap U.S. stocks, is rated as a hold because its risk-reward profile is less favorable compared to mid-cap stocks during tightening monetary policy. VTWO's recent gains are mainly due to rising valuation multiples rather than sustainable earnings growth, with nearly 30% of its companies unprofitable. Small-cap stocks also have higher exposure to floating-rate debt (30%) compared to the S&P 500 (7%), making them more vulnerable to rising interest rates. Mid-cap stocks offer a better balance of risk, business quality, and valuation, with less sensitivity to monetary tightening, making them a potentially safer choice in the current environment.
The Vanguard Russell 2000 ETF (VTWO) is discussed here, with Pluang's market data providing context on U.S. stocks. For readers following U.S. equities, as of Sep 17, 2026 21:21 WIB, out of 150 priced stocks on Pluang, 102 rose and 46 fell. Notable movers include PLUG at USD 2.15 with a 6.68% gain but 90% sell order activity, ASX at USD 40.03 with a 5.48% gain and 100% buy order activity, and MRVL at USD 242.28 with a 5.47% gain but 78% sell order activity.
Interim results from the Phase 3 DASL-HiCaP trial show that adding darolutamide to standard androgen deprivation therapy (ADT) and radiation therapy reduces the risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence...
Anthropic reported a massive increase in revenue, reaching $16.3 billion in the first half of 2026 compared to just $1.1 billion in the same period last year. This surge highlights rapid growth and strong demand for its products or services. The dram...
LlamaLend V2 strategy using 20x leverage on syrupUSDC reported a 37.1% yield, while another pool pairing sUSG with reUSD showed a 13.4% yield. The platform isolates lending markets with separate price feeds and borrowing caps, allowing supported Curv...
Solayer Pay has expanded its card app to accept stablecoin deposits directly from five blockchain networks: Solana, Ethereum, Arbitrum, BNB Chain, and Base. This update simplifies the process for users to fund their cards using stablecoins across mul...
Vertex Pharmaceuticals presented updates on its kidney disease research and development programs at the American Society of Nephrology (ASN) Kidney Week 2026. The event featured discussions on their portfolio, including new data on the AMKD program w...
